NADAC acquisition cost data for AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00378057701 | $0.4287 | 2022-07-20 | Rx |
| 00378057705 | $0.4287 | 2022-07-20 | Rx |
| 00555048302 | $0.4287 | 2022-07-20 | Rx |
| 00555048305 | $0.4287 | 2022-07-20 | Rx |
| 00378057701 | $0.4287 | 2022-07-20 | Rx |
| 00378057705 | $0.4287 | 2022-07-20 | Rx |
| 00555048302 | $0.4287 | 2022-07-20 | Rx |
| 00555048305 | $0.4287 | 2022-07-20 | Rx |
| 00378057701 | $0.4287 | 2022-07-20 | Rx |
| 00378057705 | $0.4287 | 2022-07-20 | Rx |
Generic: Amiloride HCl | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $2.3M | 100,314 | 24,310 | $0.2672 |
| 2020 | $2.3M | 102,774 | 24,351 | $0.2446 |
| 2021 | $2.2M | 102,241 | 25,199 | $0.2374 |
| 2022 | $2.1M | 104,574 | 25,498 | $0.2261 |
| 2023 | $2.2M | 107,631 | 26,467 | $0.2227 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.